DAVID P PERRY
CIK 1105941 · Executive Chairman · last filed 2024-01-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
19
Lifetime Open-Market Net
$11.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Better Therapeutics, Inc. (BTTX) Delisted | Executive Chairman | 14,607,132 | $0.04 | $651.5K | $14.33M | 8 | 2024-01-10 |
| EVLO | Director | — | $0.00 | — | $0 | 3 | 2021-06-11 |
| Anacor Pharmaceuticals, Inc. (ANAC) Delisted | President and CEO | 361,306 | $10.19 | $3.68M | -$3.29M | 8 | 2014-03-06 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-13 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2014-03-06 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Sell (S) | −65,000 | -$1.31M | EDGAR |
| 2014-02-10 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-02-05 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Sell (S) | −15,000 | -$255.0K | EDGAR |
| 2014-01-09 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Sell (S) | −65,000 | -$1.06M | EDGAR |
| 2013-12-09 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Mixed | +245,152 | -$483.3K | EDGAR |
| 2013-04-16 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-14 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-04-04 | Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.